Basic/Clinical Science Session
Untangling Determinants of AKI Through an -Omics Approach, Including the Robert W. Schrier, MD, Endowed Lectureship
November 03, 2022 | 02:00 PM - 04:00 PM
Location: W308, Orange County Convention Center, West Building
Session Description
This session discusses how -omics approaches can advance the treatment of AKI by identifying critical pathways and biomarkers and paving the way to precision medicine.
ASN gratefully acknowledges Otsuka America Pharmaceutical, Novartis, Astellas Pharma US, and several individuals for support of the Robert W. Schrier, MD, Endowed Lectureship.
Learning Objective(s)
- Describe the spatially mapped transcriptomic signature of AKI
- Discuss applications of proteomics in the treatment of AKI
- Discuss applications of metabolomics in the treatment of AKI
- Outline how advances in unbiased tissue interrogation approaches may help to redefine AKI
Learning Pathway(s)
- AKI and Critical Care
Moderators
- Eugene P. Rhee, MD
- Tomokazu Souma, MD, PhD
Presentations
- Spatial Transcriptomics in AKI
02:00 PM - 02:30 PM
Eryn E. Dixon, PhD
- Proteomics in AKI
02:30 PM - 03:00 PM
Roman-Ulrich Mueller, MD
- Metabolomics in AKI
03:00 PM - 03:30 PM
Samir M. Parikh, MD, FASN
- Integrating Analysis of Animal Models and Human Biopsies to Better Understand AKI: The Robert W. Schrier, MD, Endowed Lectureship
03:30 PM - 04:00 PM
Lloyd G. Cantley, MD, FASN
